Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13822490 | 0.76 | — | — | |
| SCHEMBL23252686 | 0.74 | TDP1 (0.30) | TDP1 | |
| SCHEMBL14272687 | 0.74 | — | — | |
| SCHEMBL6677273 | 0.74 | — | — | |
| SCHEMBL4450588 | 0.74 | — | — | |
| SCHEMBL23260742 | 0.71 | — | — | |
| SCHEMBL13381087 | 0.69 | — | — | |
| SCHEMBL14539992 | 0.69 | — | — | |
| SCHEMBL9517594 | 0.69 | — | — | |
| SCHEMBL13381138 | 0.69 | TDP1 (0.33) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6822000-B2 | ORTHOPEDIC IMPLANTS OR VEHICLES FOR THE SUSTAINED DELIVERY OF PHARMACEUTICAL, COSMETIC AND AGRICULTURAL AGENTS CONTAIN HYDROGEN BONDING GROUPS AND ALPHA-HYDROXY ACID-CONTAINING GROUPS | AP PHARMA, INC. | 2004-11-23 | — | — | US | disclosed |
| EP-1395626-A1 | PEG-POE, PEG-POE-PEG, AND POE-PEG-POE BLOCK COPOLYMERS | AP Pharma, Inc. (US) | 2004-03-10 | — | — | EP | disclosed |
| EP-1385485-A1 | BIOERODIBLE POLY(ORTHOESTERS) FROM DIOXOLANE-BASED DIKETENE ACETALS | A.P. Pharma, Inc. (US) | 2004-02-04 | — | — | EP | disclosed |
| US-20030152630-A1 | PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers | AP PHARMA, INC. | 2003-08-14 | — | — | US | disclosed |
| US-20030130472-A1 | Bioerodible poly (orthoesters)from dioxolane-based diketene acetals | AP PHARMA, INC. | 2003-07-10 | — | — | US | disclosed |
| US-6590059-B2 | Orthopedic implants or vehicles for sustained delivery of pharmaceutical, cosmetic and agricultural agents | AP PHARMA, INC. | 2003-07-08 | — | — | US | disclosed |
| WO-2002092061-A1 | BIORODIBLE POLY(ORTHOESTERS) FROM DIOXOLANE-BASED DIKETENE ACETALS | A.P. PHARMA, INC. (US) | 2002-11-21 | — | — | WO | disclosed |
| WO-2002092661-A1 | PEG-POE, PEG-POE-PEG, AND POE-PEG-POE BLOCK COPOLYMERS | AP PHARMA, INC. (US) | 2002-11-21 | — | — | WO | disclosed |
| US-20020168336-A1 | Bioerodible polyorthoesters from dioxolane-based diketene acetals | HERON THERAPEUTICS, INC. (F/K/A A.P. PHARMA, INC.) | 2002-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030152630-A1 | PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers | POF1B, GNE, PAM | TDP1 4449/4885ALDH1A1 2712/4885 |
| US-20020168336-A1 | Bioerodible polyorthoesters from dioxolane-based diketene acetals | HAAO, HAO2, HAO1 | TDP1 3448/4885ALDH1A1 121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.